IRIS
ORLANDI, ESTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.259
AS - Asia 1.931
EU - Europa 1.016
SA - Sud America 277
AF - Africa 75
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.145
SG - Singapore 578
CN - Cina 470
HK - Hong Kong 352
RU - Federazione Russa 255
VN - Vietnam 227
BR - Brasile 194
IT - Italia 158
DE - Germania 150
FR - Francia 132
GB - Regno Unito 91
BD - Bangladesh 83
IE - Irlanda 65
IN - India 61
MX - Messico 56
CA - Canada 40
FI - Finlandia 40
ZA - Sudafrica 37
AR - Argentina 32
JP - Giappone 29
PL - Polonia 22
TR - Turchia 21
AT - Austria 17
IQ - Iraq 17
SE - Svezia 16
BE - Belgio 14
CO - Colombia 14
PK - Pakistan 12
ID - Indonesia 10
VE - Venezuela 10
EC - Ecuador 9
ES - Italia 9
MY - Malesia 9
NL - Olanda 9
SA - Arabia Saudita 8
TN - Tunisia 8
IL - Israele 7
PT - Portogallo 7
CL - Cile 6
DZ - Algeria 6
EG - Egitto 6
JO - Giordania 6
UA - Ucraina 6
JM - Giamaica 5
LV - Lettonia 5
PH - Filippine 5
PY - Paraguay 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
ET - Etiopia 4
KE - Kenya 4
MA - Marocco 4
AZ - Azerbaigian 3
HN - Honduras 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
QA - Qatar 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
KH - Cambogia 1
KR - Corea 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TC - Turks e Caicos 1
TH - Thailandia 1
Totale 5.563
Salva come PNG Salva come JPEG
Città #
Dallas 501
San Jose 466
Hong Kong 341
Singapore 267
Ashburn 156
Beijing 134
Council Bluffs 115
Lauterbourg 93
Los Angeles 76
Ho Chi Minh City 74
Dublin 65
Redondo Beach 65
Hanoi 60
New York 54
Munich 50
Boardman 44
Moscow 44
Falkenstein 40
Mexico City 40
Santa Clara 40
Buffalo 36
Chandler 35
Johannesburg 30
Orem 25
Pavia 25
Tokyo 25
Montreal 24
Shanghai 24
Helsinki 21
Milan 21
São Paulo 21
Warsaw 20
Atlanta 16
Brooklyn 16
London 16
Turku 16
Changsha 15
Frankfurt am Main 15
Secaucus 15
Denver 14
Nuremberg 14
Brussels 13
Stockholm 13
Chennai 11
Da Nang 11
Haiphong 11
Boston 10
Chicago 10
Seattle 10
Düsseldorf 9
Princeton 9
Turin 9
Belo Horizonte 8
Dhaka 8
Guangzhou 8
Lawrence 8
Manchester 8
Medford 8
Phoenix 8
Ankara 7
Charlotte 7
Amman 6
Ann Arbor 6
Baghdad 6
Elk Grove Village 6
Florence 6
Hyderabad 6
Istanbul 6
Kuala Lumpur 6
Nanjing 6
Poplar 6
Rio de Janeiro 6
Rome 6
Toronto 6
Vienna 6
Wilmington 6
Brasília 5
Buccinasco 5
Bến Tre 5
Guayaquil 5
Hải Dương 5
Jacksonville 5
Medellín 5
Mumbai 5
Paris 5
Porto Alegre 5
Riga 5
Riyadh 5
San Francisco 5
Tashkent 5
Addis Ababa 4
Amsterdam 4
Houston 4
Kingston 4
Nanchang 4
New Delhi 4
Phủ Lý 4
Pittsburgh 4
Rozzano 4
Tianjin 4
Totale 3.555
Salva come PNG Salva come JPEG
Nome #
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area 298
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 110
Intravoxel incoherent motion as a tool to detect early microstructural changes in meningiomas treated with proton therapy 102
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 98
Cancer Rehabilitation and Physical Activity: the "Oncology in Motion" Project 96
Head and Neck Cancer (HNC) Prehabilitation: Advantages and Limitations 91
Using the photon isoeffective dose formalism to compare and combine BNCT and CIRT in a head and neck tumour 90
Contouring of the Pharyngeal Superior Constrictor Muscle (PSCM). A cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group 89
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach 89
Radiomics and dosiomics for predicting local control after carbon-ion radiotherapy in skull-base chordoma 85
To a new normal in radiation oncology: looking back and planning forward 79
Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy 79
Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation 78
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) 77
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients 77
Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? 76
Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy 74
A Patient Selection Approach Based on NTCP Models and DVH Parameters for Definitive Proton Therapy in Locally Advanced Sinonasal Cancer Patients 73
NR4A3 fusion molecular profile change pathological diagnosis? A case report 71
Charged particle radiotherapy for thyroid cancer. A systematic review 68
Evaluation of endocrinological sequelae following particle therapy performed on anterior skull base lesions in the adult population 66
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review 66
Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review 64
Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation 63
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 62
Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy 61
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 60
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm? 60
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 59
The Role of Neutrophil-Lymphocytes Ratio in the Prognosis of CIN2+ Recurrence after Excisional Treatment 59
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 58
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group 57
Baseline MRI-radiomics can predict overall survival in non endemic nasopharyngeal cancer patients 57
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts) 56
Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936) 55
A Dosiomics Analysis Based on Linear Energy Transfer and Biological Dose Maps to Predict Local Recurrence in Sacral Chordomas after Carbon-Ion Radiotherapy 55
AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC) 55
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? 53
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 53
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients 52
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients 52
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 51
Are there any dosimetric predictors of acute toxicity during RT for NPC that can be modulated by genetic risk factors? 50
Neutron brachytherapy in the modern era: Indications and evidence 50
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 49
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 48
Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations 48
Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy? 47
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 46
An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia 46
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 45
The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer: Inter-fraction robustness in CIRT for pancreatic cancer 45
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 44
Implementing a virtual multidisciplinary clinical case discussion to manage rare and complex head and neck cancers: an expert-defined protocol proposal from the Italian Association of Head and Neck Oncology (AIOCC) 44
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 44
Sexual Health Dysfunction After Radiotherapy for Gynecological Cancer: Role of Physical Rehabilitation Including Pelvic Floor Muscle Training 44
Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed 44
Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era 43
How can we address the challenge of distant metastases in HNSCC prognosis? 42
The Role of Carbon Ion Therapy in the Changing Oncology Landscape—A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy 42
Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma 42
Resection of the internal carotid artery in selected patients affected by cancer of the skull base 42
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 41
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report 41
Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series 40
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group 39
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 39
Current practice in proton therapy delivery in adult cancer patients across Europe 38
Moderately accelerated intensity-modulated radiation therapy using simultaneous integrated boost: Practical reasons or evidence-based choice? A critical appraisal of literature 38
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 38
Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision 38
Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity 38
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 37
How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy: RBE and LET in carbon ion therapy for sacral chordoma 36
Particle Radiotherapy for Skull Base Chondrosarcoma: A Clinical Series from Italian National Center for Oncological Hadrontherapy 36
Towards a European prospective data registry for particle therapy 35
Synthetic CT in Carbon Ion Radiotherapy of the Abdominal Site 35
INDUCTION CHEMOTHERAPY WITHIN A MULTIMODALITYREATMENT OF NASAL CAVITY AND ETHMOID SINUS MALIGNANT EPITHELIAL TUMOURS: REPORT OF AN HOMOGENEOUS SERIES OF PATIENTS 35
Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences? 35
A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group 35
Current management and future challenges in salivary glands cancer 34
Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review 34
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 34
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy 34
Quality of life changes over time and predictors in a large head and neck patients’ cohort: secondary analysis from an Italian multi-center longitudinal, prospective, observational study—a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group 34
Radiotherapy and Medical Treatment 34
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) 33
Patterns of Failure after Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy for Patients with Nasopharyngeal Carcinoma 33
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 32
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials 31
The MUSES∗: a prognostic study on 1360 patients with sinonasal cancer undergoing endoscopic surgery-based treatment 31
In Silico Feasibility Study of Carbon Ion Radiotherapy With Simultaneous Integrated Boost for Head and Neck Adenoid Cystic Carcinoma 31
Repeatability and reproducibility of MRI-radiomic features: A phantom experiment on a 1.5 T scanner 31
Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation 31
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 31
LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS 30
Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO 30
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design 30
Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram 29
Repeatability and reproducibility of MRI‐radiomic features: A phantom experiment on a 1.5 T scanner 29
Totale 5.389
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202243 0 1 0 3 0 2 1 3 4 3 4 22
2022/2023153 16 9 4 5 4 13 15 4 67 1 9 6
2023/2024107 8 9 3 8 7 14 6 16 3 2 19 12
2024/20251.345 11 25 10 10 10 103 211 116 318 56 107 368
2025/20264.010 265 555 287 409 387 130 587 174 368 376 362 110
Totale 5.687